Home > Insider Trading > Filing (0001535610-19-000067)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371217	Reshape Lifesciences Inc.	RSLS	Electromedical & Electrotherapeutic Apparatus (3845)	481293684

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1535610	Sabby Management, Llc	10 Mountainview Road Suite 205 Upper Saddle River NJ 07458		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-31	10,301	$0.27	1,192,507	No	4	P	Indirect	See Footnotes
Common Stock	Disposition	2019-02-01	1,192,000	$0.00	507	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series E Convertible Preferred Stock	Acquisiton	2019-02-01	1,192,000	$0.00	1,192,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,192,000	2019-02-01	2039-02-01	No	4	J	Indirect

Footnotes

This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor.
The amounts reported herein reflect the entire amount of the specified Issuer's security held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities and Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.
On January 31, 2019, pursuant to Section 3(a)(9) of the Securities Act of 1933, SVWMF entered into an exchange agreement with the Issuer for the exchange of 1,192,000 shares of common stock for an equal number of shares of Series E Convertible Preferred Stock ("Preferred Stock"). Each share of Preferred Stock is convertible into one share of common stock at the election of SVWMF, provided that the Preferred Stock includes a provision which limits the holder's right to convert shares of Preferred Stock into common stock such that its beneficial ownership may not exceed 9.99% of the Issuer's outstanding common stock.